Kirk Garratt, MD, has been named Clinical Director of Interventional Cardiovascular Research at Lenox Hill Hospital.
Dr. Garratt comes to Lenox Hill Hospital from The Mayo Clinic where he served as the Director of the Interventional Unit. During his tenure, he was part of the team of physicians who performed the clinics first laser angioplasty, the first directional coronary atherectomy procedure and the first coronary stent implantation procedure.
Dr. Garratt graduated from the University of California and earned his medical degree in 1983. Following his residency in Internal Medicine at the University of California Los Angeles (UCLA) Harbor Medical Center and then at Duke University, he returned to UCLA to complete his cardiology fellowship. While there, he developed an interest in interventional cardiology and participated in several angioplasty-related studies and development programs.
In 1988, he began an advanced interventional cardiology fellowship at the Mayo Clinic in Rochester, MN and was invited to join the staff after just 18 months.
While at the Mayo Clinic, he helped organize a team of physicians to develop a tele-medicine program that supported angioplasty procedures performed at hospitals without cardiac surgeons. This helped patients in rural mid-west communities who often had to travel great distances to access angioplasty. Today more than 1000 angioplasties have been performed under this program.
Dr. Garratt has made numerous original contributions to the medical literature, and participated in, or was the lead investigator in numerous clinical trials. He has published over 100 articles in peer-reviewed medical journals, written chapters for more han 30 cardiology textbooks and has published a book on angioplasty-related techniques.
Members of the press seeking information about Lenox Hill Hospital should call the Public Relations Department at (212) 434-2400.